Oncotarget – An Open-Access Multidisciplinary Journal

Oncotarget is an English name that means all substances and pathways that cause aging and cancer. Oncotarget itself is an open-access journal introduced in 2010. Its frequency of publishing papers is weekly. It has a Creative Commons Attribution 3.0 License. It has two able scientists at its helm.

Mikhail Blagosklonny is a professor of Oncology at the Roswell Park Cancer Institute since 2009. Andrei V Gudlov is Senior Vice President for Basic Research and Chair of Department of Cell Stress Biology in the same institution since 2007. The leadership of Oncotarget is no doubt under safe and qualified hands. Oncotarget has risen from an exclusively Oncology journal to a huge multidisciplinary journal. It now encompasses other subjects such as Pharmacology and Neuroscience. Oncotarget is published by Impact Journals

It provides a platform for individuals whose papers have been rejected in other journals to showcase their papers and receive constructive and insightful peer reviews. Indeed, it provides a platform for quick publishing of new findings. The punctuality and abundant peer-reviews provide a means for the papers to have maximal impact in the science community worldwide.

Oncotarget also sponsors the Gordon Research Conference. This is an annual conference aimed at not only showcasing new ideas and findings but also exposes the young and upcoming researchers. It gives them a chance to interact with the best researchers currently so that they learn by apprenticeship. This plays a role in preparing the next generation of researchers.In conclusion, Oncotarget is a noble journal aimed at promoting biomedical research with the aim of creating a disease free world. Follow Oncotarget journal on Twitter.


It mainly focuses on oncology, a part of medicine that deals with arrest, examination, and treatment of cancer. However, in the recent years, it has developed to cover the non-oncological publication. Its chief editors are Andrei V. Gudkov and Mikhail Blagosklonny who both work at Roswell Park Institute.

It usually posts its release online on a free access site to enable efficient and quick viewing of their articles. Mainly, they publish Oncology papers on DovePress.com, but due to great success, they have diversified the journal to cover other fields like cardiology, microbiology, pharmacology and neuroscience.

According to Thomson Reuters JCR Impact Factor, Oncotarget have ranked number one since the year 2011 to the present time, which is a great accomplishment for the journal. They base the success to their well-organized methods of publishing; they have the right editors with a great passion for the topics. Oncotarget is readily available via the Facebook, Twitter, YouTube, LinkedIn and Google +; this is in the spirit of reaching more audience globally.

Research on relationship between E-cigarette and gum tissue

E-cigarette refers to a battery operated device at https://twitter.com/oncotargetjrnl that causes oral danger when metal heating element evaporates. It denatures the formation of the Deoxyribonucleic acid(DNA)in that it can change the appearance of the protein, change its structure or denaturing overall tithe result is rupturing or inhibiting its intended function.

It further states that its effect resembles that of smoking in the manner in which they destroy the periodontal cells. The result of the research on YouTube discouraged any exposure to the metal heating elements as they posed more threat to the human body.

MET Amplification as potential therapeutic target in gastric cancer

It stated that the patients were responding positively to cytotoxic chemotherapy on scijournal.org. Though no exact establishment is reached, the combination of CDDPinclusive of 5 fluorouracil does help in new cases of gastric cancer.

The research done on 327 victims showed that 260 patients who were the first treated with fluoropyrimidine and platinum chemotherapy had the better chance of survival. 16 showed FGF Amplification depended on the age factor, Borman grade activities, Extra-abnormal lymph bone, and metastases.

The result revealed that independent prognostic predictor in patients worked only in the new cases while in the earlier cases it did not work. Nevertheless, to say there was no impact after being introduced in advanced stages of gastric cancer would be erroneous.